Digitalis Ventures — Full Portfolio

Judo Bio develops oligonucleotide medicines, including ligand-siRNA conjugate drugs, delivered to the kidney for systemic and renal diseases using its STRIKE (Selectively Targeting RNA Into KidnEy) platform.

BiotechHealthtechCambridge, US

AFAndrew Fraley(Co-founder)inASAlfica SehgalinOCOMMER CHOHAN(Executive Officer)inJAMES JEFFREY GOATER(Executive Officer, Director)SRSimon Read(CEO)inWHWilliam Ho

Co-investorsATAtlas VentureTHThe Column GroupDRDroia VenturesYKYK Bioventures

Gallant develops regenerative medicine therapies for veterinary care, bringing treatments from laboratory research into clinical practice for pets.

BiotechHealthtechMedical DevicesSan Diego, US

Aaron Hirschhorn(Executive Officer, Director)LBLinda Black(Chief Executive Officer, Chief Financial Officer & Secretary)inDavis Brimer(Executive Officer, Director)

BoardTBTeymour Boutros-Ghali(Director)inValentine Williams(DVM, MS, Diplomate ACVS)ASAaron Schacht(Director)

Board seatMUMisti Ushio· per SEC Form D · $18M raise · filed Jul 2025

Co-investorsALAlpha EdisonBABaroda VenturesBLBling CapitalBOBold Capital PartnersEXExpansion Venture CapitalMAMaveron+2 more

CE Brands, Inc. designs, manufactures, and distributes smart consumer electronic products, including connected health wearables and health analytics software, in partnership with manufacturers, brands, and retailers.

ConsumerHardwareHealthtechIoTNew York, US

EOEran Ofir(Executive Officer, Director)inCHCharles Herman(Executive Officer, Director)in

BoardMeir Akkerman(Director)Andrew Gianonne(Director)Christopher Geczy(Director)

Board seatDTDrew TaylorABAmit Bansal· per SEC Form D

Co-investorsEAEast Post Road Ventures

Alcea Tx develops an immune-tolerance restoration technology that targets Treg cells to reset immune homeostasis in the lungs, with a lead asset aimed at asthma and pulmonary viral infections such as influenza and SARS-CoV2.

BiotechHealthtech

Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.

BiotechDigital HealthMedical DevicesVancouver, CA

FBFrançois Bénard(MD)KLKuo-Shyan Lin(PhD)DPDavid Perrin(PhD)

Co-investorsANAndreessen HorowitzASAscenta CapitalDEDelos CapitalGEGeneral CatalystLILightspeed Venture PartnersLOLongitude Capital+9 more

Alterome is a clinical-stage precision oncology company developing small-molecule, alteration-specific cancer therapies, with two internally discovered drug candidates in the clinic.

AI & Machine LearningBiotechDeep TechSan Diego, US

Eric A. Murphy(Executive Officer, Director, Promoter)inRyan B. Corcoran(Director, Promoter)

BoardTSThilo Schroeder(Director)inCGCarl Gordon(Director)inAGArjun Goyal(Director)in

Co-investorsCACanaan PartnersNENextech InvestOROrbiMedVIVida VenturesNVNVIDIA

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.

BiotechHealthtechMedical DevicesMunich, DE

Evis Hursever(Executive Officer)Wesley McConnell(Executive Officer)inMichael Stella(Executive Officer, Director)William Hawkins(Executive Officer)

BoardMichael Beecham(Director)Andrew Kozlov(Director)

Co-investorsCACathay HealthDCDCVC (Data Collective)MOMonograph Capital Partners

Aviceda is a company that presents itself as backed by a range of investors, but the page provides no concrete details about its products or business area.

BiotechDigital HealthHealthtechMedical Devices

MAMohamed A. Genead(Chairman & CEO)inJNJeffrey Nau(Chief Executive Officer)inTarek S. Hassan(Chief Development Officer)in

Co-investorsJEJeito CapitalLOLongitude CapitalOROrbiMed

B5 Genomics offers the Benthic Analysis Platform, software that converts microarray and sequencing data (short-read and long-read) into high-resolution genotyping and variant calls for complex genomic regions such as HLA, KIR, and the MHC.

AI & Machine LearningBiotechHealthtech

Bonum Therapeutics develops antibody-controlled protein therapeutics that remain inactive until bound to their target, using a sensor-domain mechanism to deliver regulated, targeted activity.

BiotechHealthtechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inNPNeela Patel(Executive Officer)inDHDiane Hollenbaugh(Executive Officer)in

BoardSBSamuel Bjork(Director)inMSMonique Schiersing(Director)inJMJohn McKearn(Director)in

Co-investorsRIRiverVest Venture PartnersRORoche Venture FundVIVivo Capital3X3x5 PartnersCOCodon Capital

Ansel Health provides health benefit solutions focused on cost-sharing and coverage for unexpected medical bills for employer groups and individuals.

ConsumerHealthtechInsurTechHoboken, US

VGVeer GidwaneyinATAmanda Turcotte(Executive Officer)in

BoardColin Beire(Director)Elizabeth Bierbower(Director)

Co-investors50500 GlobalCICity LightFOFounder CollectiveBRBrewer Lane VenturesSISixThirty Ventures

Buddy provides a digital commerce platform for insurance that converts product rules, pricing, and workflows into structured data and deploys them as modern buying experiences across multiple channels.

AI & Machine LearningFintechInsurTechSaaS

CMCharles Merritt(Co-Founder, CEO)inDVDavid Vogeleer(Co-Founder, CTO)in

Co-investorsABAbstraction CapitalNENewlin Ventures

Candid develops clear aligner technology and offers remote monitoring services for dental professionals to deliver orthodontic treatment.

ConsumerDigital HealthHealthtechMedical Devices

NGNick Greenfield(Co-founder & CEO)in

Co-investorsA-A-Rod CorpAVAverin CapitalBEBessemer Venture PartnersBEBeyond CapitalF-F-Prime CapitalKUKube VC+2 more

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBurlington, US

MEMichael E. Mendelsohn(Founder and Chief Strategy Officer)inMMMichael Mendelsohn, M.D.(Founder)in

Co-investorsBABain CapitalASAscenta CapitalDEDelos CapitalNENew Enterprise Associates (NEA)BABain Capital Life SciencesBABain Capital Tech Opportunities+4 more

CareDox (operating as SchoolCare) provides a digital health record platform for K-12 school nurse offices that manages immunizations, chronic disease information, and student health compliance reporting.

Digital HealthEdTechHealthtechForest Hills, US

HKHesky Kutscher(Executive Officer, Director)in

BoardGreg Goff(Director)Eyal Niv(Director)

Co-investorsKIKima VenturesFIFirst Round CapitalPRProlog VenturesTETEXO VenturesWEWestern Technology Investment

Clasp connects employers with healthcare students before graduation and ties student loan repayment to employment, addressing both clinical workforce shortages and student debt.

EdTechFintechHealthtechHR TechBoston, US

TMTess Michaels(Founder)in

Co-investorsCRCrosslink CapitalGSGSV VenturesJUJuvo VenturesBLBlumberg CapitalGRGradient Ventures

Clasp provides API-based infrastructure and automation for employee health benefits administration, handling quoting, group setup, open enrollment, carrier feeds, and ACA/COBRA compliance.

FintechInsurTechSaaS

Co-investorsTETerrainCRCrosslink Capital

Clasp provides API-, SDK-, and MCP-based infrastructure and automation for health benefits administration, handling quoting, group setup, open enrollment, carrier feeds, and ACA/COBRA compliance.

FintechInsurTechSaaS

Co-investorsCOConversion CapitalCRCrosslink Capital

Code Ocean is a cloud computational research platform for reproducible code, data and environments in science.

New York, US

Simon Adar(Executive Officer, Director)

BoardSTScott Tobin(Director)inJRJoshua Ruch(Director)inMarty Kahn(Director)

Co-investorsBABattery VenturesM1M12 (Microsoft's Venture Fund)RHRho Ventures

Eden Brew develops food and supplementation products designed to deliver nutrition in natural forms that align with how the human body processes nutrients, with a focus on sustainable scaling and long-term health support.

BiotechDeep TechFoodTechHealthtechImpact & Social Good

JFJim Fader(CEO)in

Co-investorsBRBreakthrough VictoriaMAMain Sequence VenturesPOPossible VenturesRARadar Ventures

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

MHMatthew Hill(Executive Officer, Director)in

BoardPZPeter Zhou(Director)inCMCain McClary(Director)inJonathan Sheena(Director)in

Co-investorsACACVC PartnersANAndreessen HorowitzRARaptor GroupTRTriatomic CapitalAMAME Cloud VenturesINIn-Q-Tel+1 more

Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time.

AI & Machine LearningBiotechHardwareHealthtechIoTSaaSCambridge, US

SISridhar Iyengar(Executive Officer, Director)inUna Ryan(Director)JKJeff Klemens(Director)inSVSonny Vu(Director)in

BoardGTGaurav Tewari(Director)inRDRobert Davoli(Director)in

Co-investorsGUGutbrain VenturesHEHemisphere Ventures LLCJOJoint EffectsOMOmega Venture PartnersSASageview CapitalTATau Ventures+2 more

Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.

BiotechMedical DevicesSan Mateo, US

ALAnn Lee-Karlon(Executive Officer, Director)inMitchell Mutz(Executive Officer, Director)James Wells(Director)

BoardSBSamuel Bjork(Director)inACAlexandra Cantley(Director)inSMSeiji Miyahara(Director)in

Co-investorsAVAvego BioScience CapitalGVGV (Google Ventures)MIMission BiocapitalNONovartis Venture FundRORoche Venture FundSASamsara BioCapital+4 more

Expressable provides speech therapy services using research-based techniques with a focus on family engagement and accessibility.

Digital HealthHealthtechSaaS

Leanne Sherred(President and Chief Clinical Officer)in

Co-investorsF-F-Prime CapitalHAHarbourVest Partners (Canada)LELerer Hippeau

Co-investorsNONoro-Moseley PartnersSUSustainVC

Genomics company building a multi-ancestry biobank and AI-driven analytics for clinical genetic testing and drug discovery.

HealthtechMiami Lakes, US

CDCarlos D. Bustamante(Executive Officer, Director)inArthur Polk(Executive Officer)Alexander Ioannidis(Director)

BoardWAWale Ayeni(Director)inMohit Kaushal(Director)Nicholas Katsanis(Director)

Co-investorsCECEI VenturesCICitta CapitalF-F-Prime CapitalFOFounder CollectiveFUFunction VenturesHEHelios Digital Ventures+2 more

Portfolio company acquired by Roche.

BiotechSeattle, US

JMJohn Mulligan(Executive Officer, Director, Promoter)inMitchell Mutz(Director)Nicholas Walrod(Director)

BoardJMJohn McKearn(Director)inKarl Handelsman(Director)

Co-investorsRIRiverVest Venture PartnersCOCodon CapitalRORoche Venture Fund

GRObio (GRO Biosciences) develops protein therapeutics using non-standard amino acids (NSAAs) via its GRO platform, aiming to improve protein potency, stability, and function.

BiotechDeep TechHealthtechCambridge, US

Daniel J Mandell(Chief Executive Officer)TLTracey Lodie(Executive Officer)inChristopher Gregg(Director)

BoardMing Fang(Director)Bruce Beutel(Director)Dan Becker(Director)

Co-investorsLELeaps by BayerREREDMILEDRDreamers VCRIRising TideACAccess IndustriesATAtlas Venture+2 more

Helm Health provides benefit design and member engagement tools for health plans, incorporating cost and quality data into coverage decisions, bundling claims into transparent pricing, and offering provider search functionality.

Enterprise SoftwareHealthtechInsurTechSan Francisco, US

Co-investors.4.406 Ventures3C3CC | Third Culture CapitalFLFlare Capital PartnersHEHeadwater VenturesSESemperVirens Venture CapitalINInitialized Capital

Kingdom Supercultures develops functional health ingredients using natural microbes, aiming to improve consumer health.

BiotechFoodTechHealthtechNew MaterialsWellness & Fitness

Co-investors4D4DX VenturesFOFour Acres CapitalSHShine CapitalSUSupernode VenturesBRBrand Foundry VenturesLALakehouse Venture Partners+5 more

Varda industrializes low Earth orbit by manufacturing pharmaceuticals and other specialized products in space, then returning them to Earth via reusable reentry capsules.

BiotechDeep TechSpace TechEl Segundo, US

WBWill Bruey(Co-founder)inDADelian Asparouhov(Co-founder)in

Co-investorsALAlso CapitalCACaffeinated CapitalFOFounders FundKHKhosla VenturesLULux CapitalGEGeneral Catalyst+25 more

Discovering precision small molecule medicines that harness the power of covalency to transform the treatment of immune diseases.

BiotechCambridge, US

Andre Turenne(Executive Officer, Director)in

BoardJHJason Hafler(Director)inBruce Booth(Director)Daniel Becker(Director)

Co-investorsACAccess BiotechnologySASanofi VenturesACAccess IndustriesALAlexandriaATAtlas Venture

Matchpoint Therapeutics is a drug discovery company developing precision small molecule covalent medicines to treat immune and inflammatory diseases.

AI & Machine LearningBiotechDeep Tech

Andre TurenneJared Cumming(PhD)Christopher HrenThomas Durand-Reville(PhD)Wei Li(MD)Paola Castaldi(PhD)

Co-investorsATAtlas VentureSASanofi Ventures

Subscription e-commerce platform for pet owners in China.

Co-investorsCOCompanion FundDCDCM Ventures

Centennial, US

Dennis J. Chmiel(Executive Officer, Director)Jen Hagness(Executive Officer, Director)inNancy A. Willerton(Executive Officer, Director)Dennis J. Chmiel Jr.(Executive Officer, Director)

BoardCindy Cole(Director)Jeremy L. Friese(Director)

Native Pet makes veterinarian-developed nutritional supplements for dogs, including chews, powders, and bone broths that target digestion, joints, skin and coat, calming, and bladder health.

ConsumerDirect to ConsumerWellness & FitnessSt Louis, US

Patrick M Barron(Manager / Member)

Co-investorsCOCompanion FundR/R/GA VenturesSESelva VenturesCACAVU Consumer PartnersCACAVU Venture Partners

Neion Bio operates a biomanufacturing platform that re-engineers eggs into living bioreactors using genetic engineering and stem cell biology to produce biological molecules such as monoclonal antibodies, enzymes, fusion proteins, peptides, and cytokines.

Advanced ManufacturingBiotechDeep TechNew York, US

SLSam Levin(Founder)inDKDimi Kellari(Founder)in

Co-investorsCACaffeinated CapitalCLClocktower VenturesHAHAWKTAILBABasis Set VenturesENEnsemble VCHAHaystack+1 more

Nuvig Therapeutics develops immune-modulating medicines for autoimmune diseases by harnessing endogenous regulatory mechanisms to resolve immune dysregulation.

BiotechHealthtechMedical Devices

Pamela Conley(Founder)in

Co-investorsB B Capital GroupB4B4 CapitalGLGlobal BioAccess FundMIMission BiocapitalSASanofi VenturesNONorwest Venture Partners

Omni makes electric scooter attachments that connect to wheelchairs, letting wheelchair users travel on urban and off-road terrain; the company states 95% of wheelchairs are compatible with its devices.

HardwareHealthtechMobility & Transportation

Co-investors5050 PartnersCRCraft VenturesFIFirst Round CapitalGVGV (Google Ventures)ICICONIQICICONIQ Growth+6 more

Omni is a non-custodial multi-chain crypto wallet that lets users store, bridge, and swap tokens across multiple blockchains, import wallets from MetaMask, Keplr, and Phantom, build custom portfolios, and buy crypto with a credit card.

Crypto & Web3

Serafin Lion Engel(Founder)

Co-investorsFIFigmentCRCraft VenturesEMEmerge VenturesFIFirst Round CapitalGVGV (Google Ventures)ICICONIQ+9 more

Omni (formerly Steakwallet) is a non-custodial multi-chain crypto wallet that lets users store, swap, and bridge tokens across multiple blockchains, import existing wallets (MetaMask, Keplr, Phantom), earn yields, and buy crypto with a credit card.

Crypto & Web3Fintech

Co-investorsFLFlori VenturesCRCraft VenturesEMEmerge VenturesFIFirst Round CapitalGVGV (Google Ventures)ICICONIQ+9 more

Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.

AI & Machine LearningBiotechDigital Health

ANAkshay Nanduri(Founder)in

Co-investorsLILifeX VenturesKDKdT Ventures

Novel antibody-based therapeutics platform for animal health.

Co-investorsCACambridge Innovation CapitalCOCompanion FundPAParkwalk Advisors

Positive Development provides autism therapy and developmental care services for neurodivergent children and their families.

Digital HealthHealthtechMedical DevicesMental HealthMclean, US

MSMike Suiters(Executive Officer, Director)inNWNick Whitehead(Director)in

BoardASAdam Seabrook(Director)inDaniel Gebremedhin(Director)JBJohn Banta(Director)BFBrenton Fargnoli(Director)in

Co-investorsALAlleyCorpAMaMoonB B Capital GroupB4B4 CapitalFLFlare Capital PartnersLILifeforce Capital+3 more

Protego Bio is a biotech company developing first-in-class therapies for protein misfolding diseases, including its lead candidate PROT-001 for AL amyloidosis, based on research into pharmacological chaperones.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtechSan Diego, US

BJBrent J. Warner(Executive Officer, Director)inXIN JIANG(President & CEO)inHANK MICHAEL PETRASSI(Executive Officer)JEFFERY KELLY(Director)

BoardTIM LOHOFF(Director)Edward Hurwitz(Director)

Co-investorsDRDroia VenturesNONovartis Venture FundFOForbionLILightspeed Venture PartnersMPMPM BioImpactVIVida Ventures+1 more

Reema Health provides a personalized, community-based care model that connects people to health care and social support services in their local communities.

Digital HealthHealthtechImpact & Social GoodMental HealthMinneapolis, US

JLJustin Ley(CEO)inMatt(Chief Product Officer)

BoardHCHelen Ciesielski(Director)inMatthew Swanson(Director)EHEllen Herlacher(Director)inAmon Anderson(Director)

Co-investorsGRGROOVE CAPITALHCHC9 VenturesHEHeadwater VenturesLRLRVHealthMAMaC Venture CapitalMAMatchstick Ventures+3 more

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

NDNoah Davidsohn(CSO, Co-Founder)inDODaniel Oliver(CEO, Co-Founder)inGCGeorge Church(Co-Founder and SAB)DADeborah Ascheim(Chief Medical Officer)in

BoardDZDavid Zhu(Director)in

Co-investorsCOCompanion FundCOConnecticut InnovationsKEKendall Capital PartnersKDKdT Ventures

SchoolCare provides a healthcare platform focused on improving health services for children, serving schools, parents, and payers.

Digital HealthEdTechHealthtechSaaSNew York, US

Co-investors7W7wire VenturesCOCorewell Health VenturesCHCherre

Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals.

AgTechBiotechDeep TechHealthtechPhiladelphia, US

MHMark Hefferman(Executive Officer, Director)

BoardAKAditya Kohli(Director)inTadataka Yamada(Director)PHPatrick Heron(Director)inCCCindy Cole(Director)inNancy Hong(Director)

Co-investorsCOCompanion FundCOCorrelation VenturesFRFrazier Life SciencesRIRiverVest Venture Partners

Scratch Pay offers point-of-payment patient financing that lets clients of veterinary practices apply for loans and receive instant decisions, with practices paid up front via ACH.

ConsumerFintechHealthtechLos Angeles, US

CCaleb(Founder/President)JKJohn Keatley(Founder)in

Co-investorsARArgonautic VenturesCOCompanion FundNONorwest Venture PartnersSTStruck CapitalSWSWS Venture CapitalTTTTV Capital

BiotechWaltham, US

Ellen E. Sheets(Executive Officer, Director)in

BoardCarl M. Berke(Director)inNancy Hong(Director)in

Co-investorsBOBold Capital PartnersRIRiverVest Venture PartnersKDKdT Ventures

Smalls produces fresh, gently cooked cat food made to resemble home-prepared meals, differentiating itself from conventional pet food manufacturers by using minimal processing.

Direct to ConsumerFoodTech

MMMatthew Michaelson(Founder)in

Co-investorsCOCompanion FundEAEastward Capital PartnersEVEvolution VC PartnersFOFounder CollectiveIMImaginary Venture CapitalLELeft Lane Capital+3 more

Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)

BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDMDylan Morris(Director)in

Co-investorsBOBold Capital PartnersCRCRV (Charles River Ventures)FRFREEFLOWGLGlobal BrainONOno Venture Investment, Inc.UPUpfront Ventures+2 more

T-Therapeutics develops T cell receptor-based therapeutics for cancer and autoimmune diseases using its proprietary OpTiMus platform, which identifies antigen-specific human TCRs.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, GB

Co-investorsCACambridge Innovation CapitalF-F-Prime CapitalSASanofi VenturesSOSofinnova Partners

Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.

AI & Machine LearningBiotechDeep Tech

EBEli Berlin(Founder)in

BoardCPChris PicardoinDPDusan PerovicinSSSid ShenaiinSBSamuel BjorkinBassil Dahiyat, Ph.D.

Co-investorsDEDeviation CapitalMAMadrona Venture GroupSUSummit Peak InvestmentsKDKdT VenturesMAMana VenturesNVNVentures+3 more

Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.

BiotechDeep TechBoston, US

WLWayne Lencer(Co-Founder & SAB Chair)HGHunter Goble(Co-Founder & CEO)inJWJustin Wolfe(Co-Founder & CSO)in

Co-investorsPOPortal InnovationsTATau VenturesKDKdT VenturesPEPear VCTATAU VenturesXOXora Innovation Pte Ltd

Transcera is a biotech company developing a new class of therapeutics that use natural lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, targeting soluble and membrane proteins to treat chronic diseases.

BiotechDeep TechBoston, US

Co-investorsTATau Ventures

Travv develops AI-powered veterinary diagnostics, including digital pathology tools for the animal health industry.

AI & Machine LearningBiotechCloud ComputingHealthtech

DWDerick Whitley(Founder, CEO)in

Co-investorsCOCompanion Fund